Larvol Delta - BioAge-Announces-Additional-Positive-Interim-Phase-1-Data-for-BGE102-a-Novel-BrainPenetrant-NLRP3-Inhibitor-Demonstrating-Potential-for-BestinClass-hsCRP-Reduction-in-Participants-with-Elevated-Cardiovascular-Risk

BGE-102 - BioAge Labs

https://www.globenewswire.com/news-release/2026/01/12/3216965/0/en/BioAge-Announces-Additional-Positive-Interim-Phase-1-Data-for-BGE-102-a-Novel-Brain-Penetrant-NLRP3-Inhibitor-Demonstrating-Potential-for-Best-in-Class-hsCRP-Reduction-in-Participa.html

Jan 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next